Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Ye Li(University of California San Diego), David Hermanson(University of Minnesota), Branden S. Moriarity(University of Minnesota), Dan S. Kaufman(University of California San Diego)

Cell stem cell

June 28, 2018

10.1016/j.stem.2018.06.002

Cited by 982Open Access

Abstract

Related Papers

Human natural killer cells

Michael A. Caligiuri|Blood|2008|1.9k

Up on the tightrope: natural killer cell activation and inhibition

Lewis L. Lanier|Nature Immunology|2008|1.6k

Natural Killer Cell Signaling Pathways

Éric Vivier, Jacques A. Nunès, Frédéric Vely|Science|2004|731

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

Shannon L. Maude, David T. Teachey, David L. Porter et al.|Blood|2015|719

Activation of NK cell cytotoxicity

Mark J. Smyth, Erika Cretney, Janice M. Kelly et al.|Molecular Immunology|2004|717